A clinical study on CEERAKA CHOORANAM in the management of VATA PITTAM (SYSTEMIC HYPERTENSION)

A Prospective Open labelled non randomized phase II clinical study on CEERAKA CHOORANAM in the management of VATA PITTAM (SYSTEMIC HYPERTENSION)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/02/023627

Enrollment

Registered

2020-02-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I158- Other secondary hypertension

Interventions

Intervention1: CEERAKA CHOORANAM: 30mg/Kg/BW/ twice a day (Orally) A/F 50 days Control Intervention1: Nil: Nil Control Intervention2: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Known Systemic Hypertension-Stage II. (greater than and equal to 140/ greater than and equal to 90 mm/hg)-AHA Hyperlipidemia Diabetes mellitus - Type II Chronic Alcoholism Smoking

Exclusion criteria

Exclusion criteria: Known Malignant Hypertension Ischemic Heart disease Chronic Kidney Disease Chronic Liver Disease Pregnancy Lactating mother

Design outcomes

Primary

Measure	Time frame
Maintain the blood pressure within normal range according to AHA during and after treatmentTimepoint: 50 days	—

Secondary

Measure	Time frame
1. To perform the bio-chemical analysis 2. To perform the Physico chemical analysis 3. To evaluate primary phytochemical analysis in different solvents 4. To Estimate the percentage of elements present in the drug by Instrumental analysis. 5. To evaluate pharmacological activity, Acute and Sub-acute toxic activities of the trial drug.Timepoint: 50 days	—

Countries

India

Contacts

Public ContactDrAManoharan MDS PhD

Government Siddha Medical College and Hospital

drmanoharan25@gmail.com9443886700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026